S-Diclofenac
Based on 1 Customer Validation
S-Diclofenac (ACS 15) is a hybrid molecule of an H2S donor and the NSAID diclofenac. S-Diclofenac activates the p53 signaling pathway, and inhibits the activation of JNK. S-Diclofenac exhibits antioxidant and anti-inflammatory activities.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.20%
- CAS No.: 912758-00-0
- 화학식: C23H15Cl2NO2S3
- 분자량:504.47
-
보관:
4°C, stored under nitrogen, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)
Biological Activity
S-Diclofenac (0-100 μM, 48 h) induces the expression of p53 protein, thereby activating downstream proteins such as p21, p53AIP1 and Bax. S-Diclofenac arrests the cell cycle at sub-G1 phase, and induces apoptosis in rat aortic vascular smooth muscle cells[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:rat aortic vascular smooth muscle cells
-
Concentration:50 μM
-
Incubation Time:48 h
-
Result:Upregulated the expressions of p53, p21, p53AIP1 and Bax protein.
-
Cell Line:rat aortic vascular smooth muscle cells
-
Concentration:0-100 μM
-
Incubation Time:48 h
-
Result:Induced apoptosis.
S-Diclofenac (12.5-25 mg/kg, ip, one daily for 14 days) reverses the remodeling of cardiac gap junctions, alleviates oxidative stress and inflammatory response, thereby reducing Doxorubicin (HY-15142)-induced myocardial injury and cardiac dysfunction in mouse models[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Carrageenan-induced rats hindpaw edema models[2]
-
Dosage:6-24 mg/kg
-
Administration:ip, single dose
-
Result:Decreased the myeloperoxidase activity, inhibited hind paw edema.
-
Animal Model:Doxorubicin-induced mouse cardiomyopathy models[3]
-
Dosage:12.5-25 mg/kg
-
Administration:ip, one daily for 14 days
-
Result:Inhibited the downregulation of cardiac gap junction proteins Cx43 and Cx45.
Increased the activity of SOD, MPO and GSH-Px in the heart and reduced the level of MDA.
Improved the survival rate of mice.
Chemical Information
-
CAS No. 912758-00-0
-
Appearance Solid
-
분자량 504.47
-
화학식 C23H15Cl2NO2S3
-
Color Reddish brown to red
-
SMILES
O=C(CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1)OC3=CC=C(C(SS4)=CC4=S)C=C3
-
Synonyms
ACS 15; ATB-337
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
4°C, stored under nitrogen, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)
용액&용해도
DMSO : 100 mg/mL (198.23 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
순도&문서
-
Data Sheet (275 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
-
Handling Instructions (2659 KB)
References
[1]. Wallace JL, et al. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology. 2007 Jan;132(1):261-71. [Content Brief]
[2]. Sidhapuriwala J, et al., Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat. Eur J Pharmacol. 2007 Aug 13;569(1-2):149-54. [Content Brief]
[3]. Zhang H, et al., S-diclofenac protects against doxorubicin-induced cardiomyopathy in mice via ameliorating cardiac gap junction remodeling. PLoS One. 2011;6(10):e26441 [Content Brief]
[4]. Baskar R, et al., Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol. 2008 Oct 10;594(1-3):1-8. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9823 mL | 9.9114 mL | 19.8228 mL | 49.5570 mL |
| 5 mM | 0.3965 mL | 1.9823 mL | 3.9646 mL | 9.9114 mL | |
| 10 mM | 0.1982 mL | 0.9911 mL | 1.9823 mL | 4.9557 mL | |
| 15 mM | 0.1322 mL | 0.6608 mL | 1.3215 mL | 3.3038 mL | |
| 20 mM | 0.0991 mL | 0.4956 mL | 0.9911 mL | 2.4778 mL | |
| 25 mM | 0.0793 mL | 0.3965 mL | 0.7929 mL | 1.9823 mL | |
| 30 mM | 0.0661 mL | 0.3304 mL | 0.6608 mL | 1.6519 mL | |
| 40 mM | 0.0496 mL | 0.2478 mL | 0.4956 mL | 1.2389 mL | |
| 50 mM | 0.0396 mL | 0.1982 mL | 0.3965 mL | 0.9911 mL | |
| 60 mM | 0.0330 mL | 0.1652 mL | 0.3304 mL | 0.8259 mL | |
| 80 mM | 0.0248 mL | 0.1239 mL | 0.2478 mL | 0.6195 mL | |
| 100 mM | 0.0198 mL | 0.0991 mL | 0.1982 mL | 0.4956 mL |